 | • レポートコード：MRC2Q12-02493 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、メタンドロステノロン（メタンジエノン）のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 メタンドロステノロン（メタンジエノン）のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 メタンドロステノロン（メタンジエノン）の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 メタンドロステノロン（メタンジエノン）のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのメタンドロステノロン（メタンジエノン）の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のメタンドロステノロン（メタンジエノン）の売上および2028年までの予測に焦点を当てています。 メタンドロステノロン（メタンジエノン）のグローバル主要企業には、Basf、Gedeon Richter、AASraw Biochemical Technology、Asia Pioneer Pharmaceuticals、Genengin Pharma、Parr、AlphaZeneca、Norex Pharma、Teva、Magnus Pharnaceuticals、Keifei Pharma、Bolar、Rugbyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 メタンドロステノロン（メタンジエノン）市場は、タイプとアプリケーションによって区分されます。世界のメタンドロステノロン（メタンジエノン）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.98、0.99 【アプリケーション別セグメント】 子宮筋腫、小児再生不良性貧血、男性ホルモン欠乏症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - メタンドロステノロン（メタンジエノン）製品概要 - タイプ別市場（0.98、0.99） - アプリケーション別市場（子宮筋腫、小児再生不良性貧血、男性ホルモン欠乏症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のメタンドロステノロン（メタンジエノン）販売量予測2017-2028 - 世界のメタンドロステノロン（メタンジエノン）売上予測2017-2028 - メタンドロステノロン（メタンジエノン）の地域別販売量 - メタンドロステノロン（メタンジエノン）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別メタンドロステノロン（メタンジエノン）販売量 - 主要メーカー別メタンドロステノロン（メタンジエノン）売上 - 主要メーカー別メタンドロステノロン（メタンジエノン）価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.98、0.99） - メタンドロステノロン（メタンジエノン）のタイプ別販売量 - メタンドロステノロン（メタンジエノン）のタイプ別売上 - メタンドロステノロン（メタンジエノン）のタイプ別価格 ・アプリケーション別市場規模（子宮筋腫、小児再生不良性貧血、男性ホルモン欠乏症、その他） - メタンドロステノロン（メタンジエノン）のアプリケーション別販売量 - メタンドロステノロン（メタンジエノン）のアプリケーション別売上 - メタンドロステノロン（メタンジエノン）のアプリケーション別価格 ・北米市場 - 北米のメタンドロステノロン（メタンジエノン）市場規模（タイプ別、アプリケーション別） - 主要国別のメタンドロステノロン（メタンジエノン）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのメタンドロステノロン（メタンジエノン）市場規模（タイプ別、アプリケーション別） - 主要国別のメタンドロステノロン（メタンジエノン）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のメタンドロステノロン（メタンジエノン）市場規模（タイプ別、アプリケーション別） - 主要国別のメタンドロステノロン（メタンジエノン）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のメタンドロステノロン（メタンジエノン）市場規模（タイプ別、アプリケーション別） - 主要国別のメタンドロステノロン（メタンジエノン）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのメタンドロステノロン（メタンジエノン）市場規模（タイプ別、アプリケーション別） - 主要国別のメタンドロステノロン（メタンジエノン）市場規模（トルコ、サウジアラビア） ・企業情報 Basf、Gedeon Richter、AASraw Biochemical Technology、Asia Pioneer Pharmaceuticals、Genengin Pharma、Parr、AlphaZeneca、Norex Pharma、Teva、Magnus Pharnaceuticals、Keifei Pharma、Bolar、Rugby ・産業チェーン及び販売チャネル分析 - メタンドロステノロン（メタンジエノン）の産業チェーン分析 - メタンドロステノロン（メタンジエノン）の原材料 - メタンドロステノロン（メタンジエノン）の生産プロセス - メタンドロステノロン（メタンジエノン）の販売及びマーケティング - メタンドロステノロン（メタンジエノン）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - メタンドロステノロン（メタンジエノン）の産業動向 - メタンドロステノロン（メタンジエノン）のマーケットドライバー - メタンドロステノロン（メタンジエノン）の課題 - メタンドロステノロン（メタンジエノン）の阻害要因 ・主な調査結果 |
It is an androgen and anabolic steroid (AAS) medication which is still quite often used because of its affordability and effectiveness for bulking cycles
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Methandrostenolone (Metandienone) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Methandrostenolone (Metandienone) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Methandrostenolone (Metandienone) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Methandrostenolone (Metandienone) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Methandrostenolone (Metandienone) include Basf, Gedeon Richter, AASraw Biochemical Technology, Asia Pioneer Pharmaceuticals, Genengin Pharma, Parr, AlphaZeneca, Norex Pharma and Teva, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Methandrostenolone (Metandienone) production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Methandrostenolone (Metandienone) by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Methandrostenolone (Metandienone) manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Methandrostenolone (Metandienone) market. Further, it explains the major drivers and regional dynamics of the global Methandrostenolone (Metandienone) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Basf
Gedeon Richter
AASraw Biochemical Technology
Asia Pioneer Pharmaceuticals
Genengin Pharma
Parr
AlphaZeneca
Norex Pharma
Teva
Magnus Pharnaceuticals
Keifei Pharma
Bolar
Rugby
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Methandrostenolone (Metandienone) Segment by Purity
0.98
0.99
Methandrostenolone (Metandienone) Segment by Application
Uterine Fibroids
Aplastic Anemia in Children
Male Androgen Deficiency
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Methandrostenolone (Metandienone) production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Methandrostenolone (Metandienone) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Methandrostenolone (Metandienone), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Methandrostenolone (Metandienone), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Methandrostenolone (Metandienone), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methandrostenolone (Metandienone) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Methandrostenolone (Metandienone) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Methandrostenolone (Metandienone) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Basf, Gedeon Richter, AASraw Biochemical Technology, Asia Pioneer Pharmaceuticals, Genengin Pharma, Parr, AlphaZeneca, Norex Pharma and Teva, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Methandrostenolone (Metandienone) capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Methandrostenolone (Metandienone) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Methandrostenolone (Metandienone) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methandrostenolone (Metandienone) sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Methandrostenolone (Metandienone) Product Introduction
1.2 Market by Purity
1.2.1 Global Methandrostenolone (Metandienone) Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.3 Market by Application
1.3.1 Global Methandrostenolone (Metandienone) Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Uterine Fibroids
1.3.3 Aplastic Anemia in Children
1.3.4 Male Androgen Deficiency
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Methandrostenolone (Metandienone) Production
2.1 Global Methandrostenolone (Metandienone) Production Capacity (2017-2028)
2.2 Global Methandrostenolone (Metandienone) Production by Region: 2017 VS 2021 VS 2028
2.3 Global Methandrostenolone (Metandienone) Production by Region
2.3.1 Global Methandrostenolone (Metandienone) Historic Production by Region (2017-2022)
2.3.2 Global Methandrostenolone (Metandienone) Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Methandrostenolone (Metandienone) Sales in Volume & Value Estimates and Forecasts
3.1 Global Methandrostenolone (Metandienone) Sales Estimates and Forecasts 2017-2028
3.2 Global Methandrostenolone (Metandienone) Revenue Estimates and Forecasts 2017-2028
3.3 Global Methandrostenolone (Metandienone) Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Methandrostenolone (Metandienone) Sales by Region
3.4.1 Global Methandrostenolone (Metandienone) Sales by Region (2017-2022)
3.4.2 Global Sales Methandrostenolone (Metandienone) by Region (2023-2028)
3.5 Global Methandrostenolone (Metandienone) Revenue by Region
3.5.1 Global Methandrostenolone (Metandienone) Revenue by Region (2017-2022)
3.5.2 Global Methandrostenolone (Metandienone) Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Methandrostenolone (Metandienone) Production Capacity by Manufacturers
4.2 Global Methandrostenolone (Metandienone) Sales by Manufacturers
4.2.1 Global Methandrostenolone (Metandienone) Sales by Manufacturers (2017-2022)
4.2.2 Global Methandrostenolone (Metandienone) Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Methandrostenolone (Metandienone) in 2021
4.3 Global Methandrostenolone (Metandienone) Revenue by Manufacturers
4.3.1 Global Methandrostenolone (Metandienone) Revenue by Manufacturers (2017-2022)
4.3.2 Global Methandrostenolone (Metandienone) Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Methandrostenolone (Metandienone) Revenue in 2021
4.4 Global Methandrostenolone (Metandienone) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Methandrostenolone (Metandienone) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Methandrostenolone (Metandienone) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Methandrostenolone (Metandienone) Sales by Purity
5.1.1 Global Methandrostenolone (Metandienone) Historical Sales by Purity (2017-2022)
5.1.2 Global Methandrostenolone (Metandienone) Forecasted Sales by Purity (2023-2028)
5.1.3 Global Methandrostenolone (Metandienone) Sales Market Share by Purity (2017-2028)
5.2 Global Methandrostenolone (Metandienone) Revenue by Purity
5.2.1 Global Methandrostenolone (Metandienone) Historical Revenue by Purity (2017-2022)
5.2.2 Global Methandrostenolone (Metandienone) Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Methandrostenolone (Metandienone) Revenue Market Share by Purity (2017-2028)
5.3 Global Methandrostenolone (Metandienone) Price by Purity
5.3.1 Global Methandrostenolone (Metandienone) Price by Purity (2017-2022)
5.3.2 Global Methandrostenolone (Metandienone) Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Methandrostenolone (Metandienone) Sales by Application
6.1.1 Global Methandrostenolone (Metandienone) Historical Sales by Application (2017-2022)
6.1.2 Global Methandrostenolone (Metandienone) Forecasted Sales by Application (2023-2028)
6.1.3 Global Methandrostenolone (Metandienone) Sales Market Share by Application (2017-2028)
6.2 Global Methandrostenolone (Metandienone) Revenue by Application
6.2.1 Global Methandrostenolone (Metandienone) Historical Revenue by Application (2017-2022)
6.2.2 Global Methandrostenolone (Metandienone) Forecasted Revenue by Application (2023-2028)
6.2.3 Global Methandrostenolone (Metandienone) Revenue Market Share by Application (2017-2028)
6.3 Global Methandrostenolone (Metandienone) Price by Application
6.3.1 Global Methandrostenolone (Metandienone) Price by Application (2017-2022)
6.3.2 Global Methandrostenolone (Metandienone) Price Forecast by Application (2023-2028)
7 North America
7.1 North America Methandrostenolone (Metandienone) Market Size by Purity
7.1.1 North America Methandrostenolone (Metandienone) Sales by Purity (2017-2028)
7.1.2 North America Methandrostenolone (Metandienone) Revenue by Purity (2017-2028)
7.2 North America Methandrostenolone (Metandienone) Market Size by Application
7.2.1 North America Methandrostenolone (Metandienone) Sales by Application (2017-2028)
7.2.2 North America Methandrostenolone (Metandienone) Revenue by Application (2017-2028)
7.3 North America Methandrostenolone (Metandienone) Sales by Country
7.3.1 North America Methandrostenolone (Metandienone) Sales by Country (2017-2028)
7.3.2 North America Methandrostenolone (Metandienone) Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Methandrostenolone (Metandienone) Market Size by Purity
8.1.1 Europe Methandrostenolone (Metandienone) Sales by Purity (2017-2028)
8.1.2 Europe Methandrostenolone (Metandienone) Revenue by Purity (2017-2028)
8.2 Europe Methandrostenolone (Metandienone) Market Size by Application
8.2.1 Europe Methandrostenolone (Metandienone) Sales by Application (2017-2028)
8.2.2 Europe Methandrostenolone (Metandienone) Revenue by Application (2017-2028)
8.3 Europe Methandrostenolone (Metandienone) Sales by Country
8.3.1 Europe Methandrostenolone (Metandienone) Sales by Country (2017-2028)
8.3.2 Europe Methandrostenolone (Metandienone) Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Methandrostenolone (Metandienone) Market Size by Purity
9.1.1 Asia Pacific Methandrostenolone (Metandienone) Sales by Purity (2017-2028)
9.1.2 Asia Pacific Methandrostenolone (Metandienone) Revenue by Purity (2017-2028)
9.2 Asia Pacific Methandrostenolone (Metandienone) Market Size by Application
9.2.1 Asia Pacific Methandrostenolone (Metandienone) Sales by Application (2017-2028)
9.2.2 Asia Pacific Methandrostenolone (Metandienone) Revenue by Application (2017-2028)
9.3 Asia Pacific Methandrostenolone (Metandienone) Sales by Region
9.3.1 Asia Pacific Methandrostenolone (Metandienone) Sales by Region (2017-2028)
9.3.2 Asia Pacific Methandrostenolone (Metandienone) Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Methandrostenolone (Metandienone) Market Size by Purity
10.1.1 Latin America Methandrostenolone (Metandienone) Sales by Purity (2017-2028)
10.1.2 Latin America Methandrostenolone (Metandienone) Revenue by Purity (2017-2028)
10.2 Latin America Methandrostenolone (Metandienone) Market Size by Application
10.2.1 Latin America Methandrostenolone (Metandienone) Sales by Application (2017-2028)
10.2.2 Latin America Methandrostenolone (Metandienone) Revenue by Application (2017-2028)
10.3 Latin America Methandrostenolone (Metandienone) Sales by Country
10.3.1 Latin America Methandrostenolone (Metandienone) Sales by Country (2017-2028)
10.3.2 Latin America Methandrostenolone (Metandienone) Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Methandrostenolone (Metandienone) Market Size by Purity
11.1.1 Middle East and Africa Methandrostenolone (Metandienone) Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Methandrostenolone (Metandienone) Revenue by Purity (2017-2028)
11.2 Middle East and Africa Methandrostenolone (Metandienone) Market Size by Application
11.2.1 Middle East and Africa Methandrostenolone (Metandienone) Sales by Application (2017-2028)
11.2.2 Middle East and Africa Methandrostenolone (Metandienone) Revenue by Application (2017-2028)
11.3 Middle East and Africa Methandrostenolone (Metandienone) Sales by Country
11.3.1 Middle East and Africa Methandrostenolone (Metandienone) Sales by Country (2017-2028)
11.3.2 Middle East and Africa Methandrostenolone (Metandienone) Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Basf
12.1.1 Basf Corporation Information
12.1.2 Basf Overview
12.1.3 Basf Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Basf Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Basf Recent Developments
12.2 Gedeon Richter
12.2.1 Gedeon Richter Corporation Information
12.2.2 Gedeon Richter Overview
12.2.3 Gedeon Richter Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Gedeon Richter Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Gedeon Richter Recent Developments
12.3 AASraw Biochemical Technology
12.3.1 AASraw Biochemical Technology Corporation Information
12.3.2 AASraw Biochemical Technology Overview
12.3.3 AASraw Biochemical Technology Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 AASraw Biochemical Technology Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 AASraw Biochemical Technology Recent Developments
12.4 Asia Pioneer Pharmaceuticals
12.4.1 Asia Pioneer Pharmaceuticals Corporation Information
12.4.2 Asia Pioneer Pharmaceuticals Overview
12.4.3 Asia Pioneer Pharmaceuticals Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Asia Pioneer Pharmaceuticals Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Asia Pioneer Pharmaceuticals Recent Developments
12.5 Genengin Pharma
12.5.1 Genengin Pharma Corporation Information
12.5.2 Genengin Pharma Overview
12.5.3 Genengin Pharma Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Genengin Pharma Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Genengin Pharma Recent Developments
12.6 Parr
12.6.1 Parr Corporation Information
12.6.2 Parr Overview
12.6.3 Parr Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Parr Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Parr Recent Developments
12.7 AlphaZeneca
12.7.1 AlphaZeneca Corporation Information
12.7.2 AlphaZeneca Overview
12.7.3 AlphaZeneca Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 AlphaZeneca Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 AlphaZeneca Recent Developments
12.8 Norex Pharma
12.8.1 Norex Pharma Corporation Information
12.8.2 Norex Pharma Overview
12.8.3 Norex Pharma Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Norex Pharma Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Norex Pharma Recent Developments
12.9 Teva
12.9.1 Teva Corporation Information
12.9.2 Teva Overview
12.9.3 Teva Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Teva Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Teva Recent Developments
12.10 Magnus Pharnaceuticals
12.10.1 Magnus Pharnaceuticals Corporation Information
12.10.2 Magnus Pharnaceuticals Overview
12.10.3 Magnus Pharnaceuticals Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Magnus Pharnaceuticals Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Magnus Pharnaceuticals Recent Developments
12.11 Keifei Pharma
12.11.1 Keifei Pharma Corporation Information
12.11.2 Keifei Pharma Overview
12.11.3 Keifei Pharma Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Keifei Pharma Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Keifei Pharma Recent Developments
12.12 Bolar
12.12.1 Bolar Corporation Information
12.12.2 Bolar Overview
12.12.3 Bolar Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Bolar Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Bolar Recent Developments
12.13 Rugby
12.13.1 Rugby Corporation Information
12.13.2 Rugby Overview
12.13.3 Rugby Methandrostenolone (Metandienone) Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Rugby Methandrostenolone (Metandienone) Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Rugby Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Methandrostenolone (Metandienone) Industry Chain Analysis
13.2 Methandrostenolone (Metandienone) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Methandrostenolone (Metandienone) Production Mode & Process
13.4 Methandrostenolone (Metandienone) Sales and Marketing
13.4.1 Methandrostenolone (Metandienone) Sales Channels
13.4.2 Methandrostenolone (Metandienone) Distributors
13.5 Methandrostenolone (Metandienone) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Methandrostenolone (Metandienone) Industry Trends
14.2 Methandrostenolone (Metandienone) Market Drivers
14.3 Methandrostenolone (Metandienone) Market Challenges
14.4 Methandrostenolone (Metandienone) Market Restraints
15 Key Finding in The Global Methandrostenolone (Metandienone) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer